rangement, or tax benefit described in subsection (b), at 
least the following information: 
(1) The agency, program, institute, or other 
Federal Government entity providing the Federal 
support. 
(2) The amount and period of Federal financial 
support with an itemized breakdown. 
(3) Other Federal nonfinancial support, includ-
ing but not limited to the use of Federal personnel, 
Federal facilities, and Federal equipment. 
(4) The grant number, if applicable. 
(5) Associated clinical trial data, upon trial 
completion. 
(6) Associated patents and patent applications, 
specifying— 
(A) any Federal ownership in such patents 
and patent applications; 
(B) the expiration date of such patents 
and filing dates of such patent applications; and 
(C) the numbers of such patents and pat-
ent applications. 
(7) Associated periods of marketing exclusivity 
under Federal law and the durations of such peri-
ods. 
VerDate Sep 11 2014 
00:29 Jul 11, 2020
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H7288.IH
H7288
kjohnson on DSK79L0C42PROD with BILLS
(8) The corporation, nonprofit organization, 
academic institution, person, or other entity receiv-
ing the Federal support. 
(9) Any products (including repurposed prod-
ucts) approved, authorized, or cleared for marketing, 
or for which marketing approval, authorization, or 
clearance is being sought, the development of which 
was aided by Federal support, including— 
(A) the names of such products; 
(B) the prices of such products; and 
(C) the current and anticipated manufac-
turing capacity to produce such products. 
(10) The full terms of the contract, funding 
agreement, licensing arrangement, other transaction, 
or other arrangement described in subsection (b). 
(d) FORMAT OF INFORMATION.—The database under 
subsection (a) shall be— 
(1) searchable and filterable according to the 
categories of information described in subsection (c); 
and 
(2) presented in a user-friendly format. 
(e) TIMING.—The database under subsection (a) 
shall be— 
(1) made publicly available not later than 1 
month of the date of enactment of this Act; and 
VerDate Sep 11 2014 
00:29 Jul 11, 2020
Jkt 099200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H7288.IH
H7288
kjohnson on DSK79L0C42PROD with BILLS
(2) updated not less than every 2 weeks. 
(f) DISCLOSURE.— 
(1) IN GENERAL.—Notwithstanding any other 
provision of law, to the extent necessary for an offi-
cial referred to in subsection (a) to carry out this 
section, such official may require entities receiving 
Federal support referred to in subsection (a)(1) to 
disclose to the official any information relating to 
such Federal support and required to be included in 
the database under subsection (a). 
(2) PENALTY FOR NONDISCLOSURE.—If an en-
tity that is required to disclose information pursuant 
to paragraph (1) fails to disclose such information 
within a reasonable period of time or within two 
weeks of the official requesting such information, 
whichever is sooner, then such entity and all execu-
tive officers employed by such entity shall no longer 
be eligible for the receipt of Federal support in the 
form of a contract, funding agreement, licensing ar-
rangement, other transaction, or other arrangement. 
Æ 
VerDate Sep 11 2014 
00:29 Jul 11, 2020
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H7288.IH
H7288
kjohnson on DSK79L0C42PROD with BILLS